Navigation Links
The Bachmann-Strauss Dystonia & Parkinson Foundation: New Study Identifies Gene Mutations as Cause of Dystonia in Amish-Mennonite Families

Breakthrough findings contribute to better understanding of little-known disease and may lead to development of new therapies

NEW YORK, Feb. 3 /PRNewswire/ -- A new research study has identified mutations in the THAP1 gene as a cause of primary torsion dystonia (DYT6 type) in Amish-Mennonite families and cited a second mutation in a non-Mennonite family showing that THAP1 causes dystonia in other ethnic groups.

A paper entitled "Mutations in the THAP1 gene are responsible for DYT6 primary torsion dystonia" was published February 1, 2009 on-line in the journal Nature Genetics. Co-investigators on the study are Susan Bressman, MD, chair, Department of Neurology, Beth Israel Medical Center, and Laurie Ozelius, PhD, Associate Professor, and Bachmann-Strauss Professor, Mount Sinai School of Medicine, New York City.

This new body of research also revealed that the THAP1 gene has DNA binding and apoptosis (or cell death) functions, neither of which were previously associated with primary torsion dystonia. In addition it showed that the mutations in THAP1 can impair DNA binding. The protein encoded by THAP1 is predicted to bind DNA near the start site of other genes and then turn on or off the expression of those genes. Since there are a number of factors that come into play in addition to this "transcription factor", a mutation that impairs DNA binding could upset that balance and, as a consequence, turn other genes on or off, contributing to dystonia.

"The DNA binding function attributed to this gene has not previously been associated with dystonia. The discovery of this gene could help us develop new treatments in the future to prevent this debilitating disease," said Dr. Ozelius.

This is the second gene identified for primary torsion dystonia. The first, discovered ten years ago, was the DYT1 gene which was found to be mutated in most people with early onset dystonia. While people may carry the DYT1 or THAP1 genes, they may not show clinical symptoms, suggesting that other genes or environmental factors also play a role in these diseases.

"We are thrilled by these new findings, which should open up the science in many different ways," said Dr. Bressman. "Studies are underway to determine the role of THAP1 in other families and populations. Based on the families we identified, dystonia due to DYT6 is similar to DYT1 in that it starts in childhood and can affect many muscles but, unlike DYT1, people who have the DYT6 mutation are more likely to have problems in the lower face, jaw and vocal cords."

Dystonia is a neurological muscle disorder that causes uncontrollable, painful spasms in one or more parts of the body. It strikes an estimated 500,000 people in North America alone, affecting more people than muscular dystrophy, Huntington's disease and Lou Gehrig's disease combined.

The Bachmann-Strauss Dystonia & Parkinson Foundation provided funding in part for this study and for the earlier discovery of the DYT1 gene.

"This impressive discovery will play an important role in furthering our understanding of this terrible disease," said Bonnie Strauss, president and founder of the organization.

Established in 1995 to find better treatments and cures for the movement disorders, dystonia and Parkinson's disease, The Bachmann-Strauss Dystonia & Parkinson Foundation is an independent, nonprofit, 501(c)3 organization. Its funding is made possible through the generosity of individual and corporate contributors.

SOURCE The Bachmann-Strauss Dystonia & Parkinson Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Stimulating muscles may improve musicians dystonia
2. Novel Techniques Offers New Freedom to Patients with Parkinson's Disease, Epilepsy, Dystonia, and Tremor
3. Decreased activity of basal ganglia is the main cause of abnormal muscle constrictions in dystonia
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Gene Mutation Linked to Parkinsons Disease
6. Parkinsons Linked to Risk of Alzheimers
7. XShares Supports Parkinsons Disease Foundation 50th Anniversary Educational Symposium
8. Parkinsons Institute research shows that nicotine reduces levodopa-induced dyskinesias
9. NSAIDs Protect Against Parkinsons Disease
10. Ceregene Completes Enrollment of Phase 2 Clinical Trial for Parkinsons Disease
11. Relatives of Parkinsons Patients at Higher Psychiatric Risk
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... ... to discuss bioavailability and the need to integrate dose form selection in early ... with OBN, the membership organization supporting and bringing together the UK’s emerging life ...
(Date:11/26/2015)... Aliso Viejo, CA (PRWEB) , ... November 26, ... ... X users a new set of retro-fused, self-animating trailer titles with ProTrailer: Vintage. ... custom style options. These classically-influenced trailer titles work with any font, giving users ...
(Date:11/25/2015)... ... November 25, 2015 , ... As part of a ... ™ attracts volunteers together who want to combine talents and resources to help ... in the process. The non-profit launched its first major fundraiser on November 6, ...
(Date:11/25/2015)... MN (PRWEB) , ... November 25, 2015 , ... ... launched offering factory direct sauna parts and accessories. , Sauna accessories help ... of the bather’s style and personality. From basic styles for the purist looking ...
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert is donating ... Beat ” campaign. The partnership between the two groups began in 2014 with Vitalalert ... cause. , MAP International was founded in 1954 and is an international Christian-based health ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ( ... Cardiac Pacemaker Market Outlook to 2019 - Rise in Cardiac ... " report to their offering. ... Boston scientific and others. --> ... Medtronic, Biotronik, Boston scientific and others. ...
(Date:11/26/2015)... Research and Markets ( ) ... Future Horizons and Growth Strategies in the Japanese ... Segment Forecasts, Competitive Intelligence, Emerging Opportunities" report ... --> This new 247-page report ... drug monitoring market, including emerging tests, technologies, instrumentation, ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the Global Cell Surface Testing ... Opportunities" report to their offering.  ... the addition of the  "2016 Future ...
Breaking Medicine Technology: